Press Releases Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
37.51 ^USD	0.00%		+2.99%	+21.86%

29/04	Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER	CI
11/04	Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PTAB's Authority To Issue A Final Written Decision After A Statutory Deadline	03/05	AQ
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER	29/04	GL
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024	25/04	GL
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026	11/04	GL
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026	11/04	AQ
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference	03/04	GL
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference	03/04	AQ
Collegium Pharmaceutical: Q4 Earnings Snapshot	23/02	AQ
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results	23/02	GL
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results	23/02	AQ
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024	08/02	GL
Deadline Dexterity: PTAB Has Authority To Issue Decisions After Statutory Deadline	18/01	AQ
Collegium Provides 2024 Financial Guidance	03/01	GL
No Consequence For Board Issuing Final Written Decision Over 37 Months After Institution	13/12	AQ
Purdue v. Collegium: Upholding The Board's Authority To Issue A Final Written Decision Even After The Statutory Deadline Has Passed	08/12	AQ
Federal Circuit Patent Watch: Avoid Fighting With The Courts And Administrative Agencies	30/11	AQ
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent	27/11	GL
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent	27/11	AQ
Collegium Announces $25 Million Accelerated Share Repurchase Program	09/11	GL
Collegium Announces $25 Million Accelerated Share Repurchase Program	09/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Press Releases

Filters